urine cytology
CT urography
cystoscopy
renal function tests
D. renal function tests
there will be no target tumor tissue to work on
post-op. hematuria interacts unfavorably with BCG composition
of the risk of systemic absorption and sepsis
of the high risk of BCG reflux to kidneys while bladder irrigation
upper ureter
middle ureter
lower ureter
comparable
frequently found in association with high-grade or extensive TCC
has a rate of progression to muscle invasion of 10-25%
significant areas of CIS are easily missed by routine cystoscopy
treatment begins with TURBT
radical cysto-prostatectomy
anterior pelvic exenteration
bilateral pelvic lymphadenectomy
creation of a urinary diversion
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
obesity
consuming artificial sweeteners
asbestosis
analgesic abuse
2%
5%
70%
90%
never
unlikely
likely
always
multifocality
high tumor grade and advanced stage
presence of CIS
all of the above
mid prostate to the verumontanum at the 5 and 7 oclock positions
lateral margins of the prostate at the 10 and 2 oclock positions
entire area distal to the urethral crest
area between ejaculatory duct openings and prostatic utricle
10%
20%
30%
40%
epirubicin
mitomycin c
BCG
none of the above
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
comparable
transitional cell carcinoma
squamous cell carcinoma
adenocarcinoma
small cell carcinoma
obstructive LUTS are common presentations and occur in association with carcinoma in situ
might present as perineal abscesses and fistulae
could be asymptomatic
venereal diseases increase the risk of urethral cancers
en bloc resection involving total penectomy, cystoprostatectomy, resection of the pubic rami and urogenital diaphragm, with pelvic lymphadenectomy. In addition, creating a urinary diversion.
total penectomy involving removal of the penis, urethra, and penile root
partial penectomy involving excision of the malignant lesion with 2-cm margins
transurethral resection or fulguration
irritative bladder symptoms
obstructive bladder symptoms
palpable suprapubic mass on physical examination
painless profuse hematuria
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
high specificity
high sensitivity
high reliability
strong validity
rarely diagnosed at autopsy
the peak incidence occurs between ages 70 and 80
they occur twice as frequently in men as in women
none of the above
urine cytology
CT urography
cystoscopy
renal function tests
the standard treatment is transurethral resection
the prognosis for inverted papilloma is pathetic, with a recurrence rate of approximately 65%
the likelihood of synchronous urothelial carcinoma is 26%
has been shown to harbor p53 gene mutations
only in females
associated with chronic irritation, polypoid cystitis, and cystitis glandularis
no risk for squamous cell carcinoma
treated with estrogen, if symptomatic
40 - 55%
55 - 70%
70 - 85%
85 - 100%
the anterior urethra drains into the inguinal and pelvic nodes
the posterior urethra drains into the pelvic nodes
the proximal two-thirds drain into the external and internal iliac nodes
the distal one-third drains into the obturator nodes
sensitivity to chemotherapy and age at presentation
anatomic location and extent of the tumor
histologic type of the tumor and sensitivity to radiotherapy
tumors stage and grade
leiomyoma
hemangioma
fibroepithelial polyp
lymphangioma
cisplatin
BCG
mitomycin C
5-fluorouracil
working with organic chemicals and dyes
abuse of pain-control medications especially phenacetin
exposure to arsenic and aromatic amines
schistosomiasis